Table 1.
Types | Source | Features | Limitations | References |
---|---|---|---|---|
Cell-secreted exosomes | Human embryonic kidney (HEK) cells | Membrane resemblances to various tissues in our body Immunologically inert High efficiency in transfection |
Low yield compared to body fluid and food-derived exosomes | [31,32] |
Cancer cells | Tropism toward their parent cells | Less ideal pharmacokinetic profile Lack of studies for metastatic role of cancer cell exosomes |
[33,34,35] | |
Immune cells (e.g., dendritic cells) |
Strictly defined molecular compositions Expression of NK cell-stimulating ligand peptides Surface modification using targeting moieties |
Lack of understanding of DEX components (e.g., mRNAs, miRs, and cytokines) and mechanisms regarding how these factors interact with acceptor cells | [36,37,38,39,40] | |
Stem cells (e.g., mesenchymal stem cell) |
Easy availability from ethically acceptable tissues Large capacity for ex vivo expansion |
Similar to other types of exosomes (e.g., lack of PK database and need to improve production efficiency) |
[41,42,43] | |
Blood-derived exosomes | Blood (red blood cells) |
Relatively high yield from a single blood unit Reduced unexpected mutations from cell culture No occurring horizontal gene transfer Non-toxic/immunogenic by matching blood types High transfection efficiency |
Not determined | [43,44] |
Food-derived exosomes | Milk-derived exosomes | Dosing through less-invasive oral cavity Functionalized by simple post-insertion |
Variation in shape, size, and cargo contents of exosomes depending on the diet and condition of the source Less understanding of the endogenous biological cargo of milk exosomes |
[45,46,47,48] |
Edible plants-derived exosomes (e.g., ginger, grapes, lemon, etc.) |
Limited knowledge of cellular molecular properties of PDEs | [49,50,51] |